<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disease caused by mutations in fibroblast growth factor receptor (FGFR-2) and characterized by premature fusion of the cranial sutures and early epiphyseal closure </plain></SENT>
<SENT sid="1" pm="."><plain>The development of widespread, severe, pustular <z:hpo ids='HP_0001061'>acne</z:hpo> around puberty is a characteristic feature in these patients </plain></SENT>
<SENT sid="2" pm="."><plain>The FGFR-2 mutation of <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> has been described in localized nevoid <z:hpo ids='HP_0001061'>acne</z:hpo> lesions, which have been attributed to <z:hpo ids='HP_0001442'>somatic mosaicism</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="6067">Isotretinoin</z:chebi> has been reported to be useful in controlling this <z:hpo ids='HP_0001061'>acne</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We report the successful treatment of <z:hpo ids='HP_0001061'>acne</z:hpo> with <z:chebi fb="0" ids="6067">isotretinoin</z:chebi> in a teenager with <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> and review the pathophysiology of <z:hpo ids='HP_0001061'>acne</z:hpo> in this syndrome </plain></SENT>
</text></document>